热门标签

嘉和生物(06998.HK)治疗肺癌创新药临床试验获批

时间:1个月前   阅读:27   评论:2
嘉和生物-B(06998.HK) 公布,已获得国家药监局关于GB263T临床试验I/II期的临床试验批准。GB263T用于治疗晚期非小细胞肺癌及其他实体瘤患者,是全球首个EGFR/cMET/cMET三特异性抗体。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2022-06-06 16:25。)

上一篇:手机新2管理端(www.hg108.vip)_疑被戴绿帽 莽男怒砸餐厅呛「拐别人老婆上床」下场曝

下一篇:皇冠正网(www.hg108.vip)_东部战区战备警巡:“就是针对美台勾连”

网友评论

  • 2022-07-02 00:00:23

    “I have not received any letter from him (Mohamaddin). He announced it. I think sometimes people have all sort of feelings,” he said, commenting on Mohamaddin’s announcement today that he has quit Bersatu, less than a year after he joined the party after exiting Warisan last year.总觉得你可以更好